Pathogenesis of Glaucomatous Optic Nerve Damage
青光眼视神经损伤的发病机制
基本信息
- 批准号:7525618
- 负责人:
- 金额:$ 58.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:1 year old1-Phosphatidylinositol 3-Kinase3-DimensionalAccountingAcepromazineActive SitesAcuteAdoptedAdultAdverse effectsAffectAfricanAgeAge-MonthsAirAlgorithmsAmacrine CellsAmilorideAmyloid beta-Protein PrecursorAnatomyAnesthesia proceduresAnimalsAnisotropyAnnexinsAnteriorAntibodiesAortaApoptosisApoptoticAppearanceAreaAstrocytesAtlasesAttenuatedAutoantibodiesAwardAxonAxonal TransportBackBehaviorBiochemicalBiological AssayBiological PreservationBiomechanicsBirthBlood PressureBlood VesselsBlood capillariesBlood flowBody TemperatureBrainBrain-Derived Neurotrophic FactorBreedingBuffersBurr hole procedureCCAAT-Enhancer-Binding ProteinsCaliberCalibrationCandidate Disease GeneCannulasCannulationsCattleCell CountCell DeathCell NucleusCell SurvivalCell TherapyCell physiologyCellsCellular MorphologyCellular StructuresCeruloplasminCessation of lifeCharacteristicsChemicalsChoroidChronicCiliary BodyCiliary Neurotrophic FactorClassificationClinicalCodeCollagenCollagen FibrilCollagen GeneCollagen Type ICompanionsComplementary DNAComplexComputer softwareConfocal MicroscopyConnective TissueConnective Tissue AlterationCopaxoneCorneaCrush InjuryCryopreservationCryoultramicrotomyCytolysisCytoprotectionDataData CollectionDefectDendritesDeteriorationDevelopmentDevicesDiastolic blood pressureDigoxigeninDimensionsDistalDoctor of PhilosophyDoseDropsDyesDynein ATPaseEconomic InflationEdetic AcidEhlers-Danlos SyndromeElastinElastin FiberElementsEndothelinEndothelin ReceptorEngineeringEnglandEuropeanEvaluationEventExcisionExfoliation SyndromeExhibitsExposure toExpressed Sequence TagsEyeEye BanksFBN1FOS geneFailureFamily suidaeFeedbackFerritinFiberFibrillar CollagenFibroblastsFilmFluorescenceFluorochromeFreezingFrozen SectionsFundingGanglion Cell LayerGene ActivationGene ClusterGene ExpressionGene MutationGenesGlassGlaucomaGluesGlyceraldehydeGrantGraphGray unit of radiation doseGrowthGrowth FactorHandHeadHeat shock proteinsHeightHigh PrevalenceHistocytochemistryHomozygoteHourHumanHuman bodyHydration statusHydrophthalmosImageImage AnalysisImmediate-Early GenesImmunoblottingImmunofluorescence ImmunologicImmunohistochemistryIn SituIn Situ HybridizationIn VitroInbred StrainIncidenceIndia ink stainIndiumIndividualInduced MutationInfantInferiorInflammationInflammatoryInjection of therapeutic agentInjuryInner Nuclear LayerInvestigationInvestmentsJUN geneJawKeratoconusKetamineKnock-outKnockout MiceLabelLaboratoriesLasersLateral Geniculate BodyLeadLeftLengthLeucineLifeLightLinkLiquid substanceLocationLong-Term EffectsLosartanMAPK10 geneMAPK14 geneMAPK8 geneMaintenanceManuscriptsMapsMarfan SyndromeMasksMatrix MetalloproteinasesMeasurableMeasurementMeasuresMechanicsMediatingMediator of activation proteinMedical TechnologyMembraneMeridiansMessenger RNAMethodologyMethodsMicroscopeMicroscopicMicrospheresMitogen-Activated Protein KinasesModelingMolecularMolecular StructureMonitorMonkeysMorphologyMotorMouse ProteinMouse StrainsMovementMultivariate AnalysisMusMuscleMutant Strains MiceMutateMutationMydriasisMyopiaNamesNatural regenerationNeedlesNerveNerve CrushNerve DegenerationNerve FibersNerve Growth Factor ReceptorsNerve TissueNeuritesNeurofilament-HNeurogliaNeuronsNeurosciences ResearchNeurotransmittersNormal salineNuclearObstructionOcular HypertensionOpen-Angle GlaucomaOperative Surgical ProceduresOphthalmoscopyOptic DiskOptic NerveOptic Nerve InjuriesOptic Nerve TransectionsOpticsOrganellesOryctolagus cuniculusOsmiumOutcomeOutcome MeasureOutcome StudyPaperPartner in relationshipPathogenesisPathway interactionsPatternPeer ReviewPerfusionPeripheralPermeabilityPeroxidasesPersonsPharmaceutical PreparationsPhasePhenotypePhenylephrinePhosphorylationPhysiologic Intraocular PressurePhysiologicalPhysiologyPolyethylenesPolystyrenesPositioning AttributePredispositionPresynaptic TerminalsPrevalencePreventivePrimatesProcessProductionProgress ReportsPropertyProtease InhibitorProtein DephosphorylationProtein Kinase CProtein-Lysine 6-OxidaseProteinsProtocols documentationPublicationsPublishingPumpPyroxylinRNARadialRadioactiveRampRattusReactionReadingRecoveryRelative (related person)RelaxationReportingResearchResearch DesignResearch PersonnelResolutionRetinaRetinalRetinal Ganglion CellsReverse TranscriptionRiboflavinRibonucleasesRiluzoleRiskRisk FactorsRodentRoleSagittariaSalineSample SizeSamplingScaffolding ProteinScintillation CounterScintillation CountingScleraSecureSedation procedureSerumSideSignal PathwaySignal TransductionSimulateSiteSkinSlideSodium Dodecyl Sulfate-PAGESolutionsSourceSpecific qualifier valueSpecimenSpottingsStagingStaining methodStainsStem cellsStressStress TestsStretchingStructureSubgroupSucroseSuggestionSupravalvular aortic stenosisSurfaceSurgical incisionsSyringesTNF geneTRAAK channelTailTechniquesTechnologyTemperatureTendon structureTestingTheoretical modelTherapeuticThickThree-dimensional analysisThromboplastinThrombospondin 1TimeTissue ModelTissue SampleTissuesTo specifyTolonium chlorideToxic effectTransducersTransferrinTransforming Growth Factor betaTransgenic MiceTransgenic OrganismsTranslatingTranslationsTransmission Electron MicroscopyTravelTreesTrephine holeTropicamideTropoelastinTumor Necrosis Factor-alphaTumor Necrosis FactorsTupaiidaeUltraviolet RaysUp-RegulationVaccinationVariantVial deviceVisual FieldsVisual PathwaysWallerian DegenerationWestern BlottingWood materialWorkXylazineactive controladeno-associated viral vectoraerobic respiration control proteinaggrecananterior chamberanterograde transportbasebiglycanbonecDNA ArrayscDNA Librarycalbindincalbindin-D28Kcapillarycell injurycellular engineeringcentral retinal arterycomparativecomputerized data processingcongenicconnective tissue developmentcrosslinkcyclin D2cytokinedensitydesigndigitaldigital imagingdynactinexperiencefibrillinfibromodulinfluorescence microscopeganglion cellgene therapyhigh intraocular pressurehorizontal cellhuman diseaseimaging modalityimprovedin vivoinhibitor/antagonistinjuredinstrumentinterestkillingslaser capture microdissectionlectureslenslumicanmRNA Expressionmature animalmicrosystemsmorphometrymouse modelmutantmyocilinneonatal humannestin proteinneurofilamentneuroinflammationneuronal cell bodyneurotrophic factorneutralizing antibodynoveloverexpressionparaformparticlepressurepreventprimary outcomeprogramspromoterprotective effectrat genomeregional differencerelating to nervous systemresearch studyresponseresponse to injuryrestorationretinal damageretinal neuronretrograde transportsecondary outcomestress-activated protein kinase 1successsuperior colliculus Corpora quadrigeminasyntaxintraittranscription factortransmission processtwo-dimensionalvalidation studies
项目摘要
To reduce the project to a 2 year proposal, I have retained the overall theme which is to study the effect of connective tissues of the sclera and peripapillary nerve head on axonal injury and RGC death. The portions of the 5 year proposal that were eliminated were much of former Aim 2 and 3 which dealt with studies of nerve head capillary function, and the roles of endothelin and tumor necrosis factor _ in RGC injury. We expect to test the role of connective tissue alteration in the ultimate survival of RGC in chronic experimental glaucoma (former Aim 4, now Aim 3), including the effect of chemical scleral cross-linking. To complete the project in 2 years, we eliminated from the 5 year proposal Hypotheses 7, 8, 9, and 11.
为了将该项目缩短为2年的提案,我保留了总体主题,即研究巩膜和视乳头周围神经乳头的结缔组织对轴突损伤和RGC死亡的影响。取消的5年计划部分是以前的目标2和3,涉及研究神经头毛细血管功能,以及内皮素和肿瘤坏死因子在RGC损伤中的作用。我们期望测试结缔组织改变在慢性实验性青光眼中RGC最终存活中的作用(以前的目标4,现在的目标3),包括化学巩膜交联的作用。为了在2年内完成项目,我们从5年提案中删除了假设7、8、9和11。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harry Alan Quigley其他文献
Harry Alan Quigley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harry Alan Quigley', 18)}}的其他基金
Pathogenesis of Glaucomatous Optic Nerve Damage
青光眼视神经损伤的发病机制
- 批准号:
7646697 - 财政年份:2008
- 资助金额:
$ 58.56万 - 项目类别:
The Wilmer Institute Mentored Clinician Scientist Scholar Program-Supplement
威尔默研究所指导临床医生科学家学者计划-补充
- 批准号:
10405937 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:
The Wilmer Institute Mentored Clinical-Scientist Scholar Program
威尔默研究所指导临床科学家学者计划
- 批准号:
8088099 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:
The Wilmer Institute Mentored Clinical-Scientist Scholar Program
威尔默研究所指导临床科学家学者计划
- 批准号:
8509693 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:
Wilmer Inst. Mentored Clinical Research Scholar Program
威尔默研究所。
- 批准号:
7064236 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:
The Wilmer Institute Mentored Clinician Scientist Scholar Program
威尔默研究所指导临床科学家学者计划
- 批准号:
9274400 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:
The Wilmer Institute Mentored Clinical-Scientist Scholar Program
威尔默研究所指导临床科学家学者计划
- 批准号:
7844468 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:
The Wilmer Institute Mentored Clinical-Scientist Scholar Program
威尔默研究所指导临床科学家学者计划
- 批准号:
8293266 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:
The Wilmer Institute Mentored Clinician Scientist Scholar Program
威尔默研究所指导临床科学家学者计划
- 批准号:
10203987 - 财政年份:2003
- 资助金额:
$ 58.56万 - 项目类别:














{{item.name}}会员




